David Hyman - Net Worth and Insider Trading
David Hyman Net Worth
The estimated net worth of David Hyman is at least $26,775 dollars as of 2024-09-20. David Hyman is the Senior Officer of Rakovina Therapeutics Inc and owns about 315,000 shares of Rakovina Therapeutics Inc (TSXV:RKV) stock worth over $26,775. Details can be seen in David Hyman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Hyman has not made any transactions after 2023-01-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Hyman
David Hyman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Hyman owns 1 companies in total, including Rakovina Therapeutics Inc (TSXV:RKV) .
Click here to see the complete history of David Hyman’s form 4 insider trades.
Insider Ownership Summary of David Hyman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2023-01-18 | Senior Officer |
David Hyman Latest Holdings Summary
David Hyman currently owns a total of 1 stock. David Hyman owns 315,000 shares of Rakovina Therapeutics Inc (TSXV:RKV) as of January 18, 2023, with a value of $26,775.
Latest Holdings of David Hyman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSXV:RKV | Rakovina Therapeutics Inc | 2023-01-18 | 315,000 | 0.09 | 26,775 |
Holding Weightings of David Hyman
David Hyman Form 4 Trading Tracker
According to the SEC Form 4 filings, David Hyman has made a total of 1 transactions in Rakovina Therapeutics Inc (TSXV:RKV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Rakovina Therapeutics Inc is the acquisition of 70,000 shares on January 18, 2023, which cost David Hyman around $10,143.
Insider Trading History of David Hyman
- 1
David Hyman Trading Performance
GuruFocus tracks the stock performance after each of David Hyman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Hyman is -9.38%. GuruFocus also compares David Hyman's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Hyman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Hyman's insider trading performs compared to the benchmark.
Performance of David Hyman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25 | | | | | |
| Relative Return to S&P 500(%) | -28.82 | | | | | |
David Hyman Ownership Network
David Hyman Owned Company Details
What does Rakovina Therapeutics Inc do?
Who are the key executives at Rakovina Therapeutics Inc?
David Hyman is the Senior Officer of Rakovina Therapeutics Inc. Other key executives at Rakovina Therapeutics Inc include Senior Officer Mads Daugaard , Senior Officer Jeffrey Bacha , and Director & Senior Officer Alfredo De Lucrezia .
Rakovina Therapeutics Inc (TSXV:RKV) Insider Trades Summary
Over the past 18 months, David Hyman made no insider transaction in Rakovina Therapeutics Inc (TSXV:RKV). Other recent insider transactions involving Rakovina Therapeutics Inc (TSXV:RKV) include a net purchase of 145,000 shares made by Jeffrey Bacha , a net purchase of 107,143 shares made by Alfredo De Lucrezia , and a net purchase of 25,000 shares made by Mads Daugaard .
In summary, during the past 3 months, insiders sold 0 shares of Rakovina Therapeutics Inc (TSXV:RKV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rakovina Therapeutics Inc (TSXV:RKV) were sold and 277,143 shares were bought by its insiders, resulting in a net purchase of 277,143 shares.
Rakovina Therapeutics Inc (TSXV:RKV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rakovina Therapeutics Inc Insider Transactions
David Hyman Mailing Address
Above is the net worth, insider trading, and ownership report for David Hyman. Currently GuruFocus does not have mailing address information for David Hyman.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
